CCP
LH icon

Corient Capital Partners’s Labcorp LH Stock Holding History

Corient Capital Partners’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$353K Buy
1,754
+95
+6% +$19.4K 0.03% 419
2022
Q2 		$334K Sell
1,659
-152
-8% -$32.4K 0.03% 444
2022
Q1 		$410K Buy
1,811
+199
+12% +$46.8K 0.03% 428
2021
Q4 		$435K Buy
1,612
+17
+1% +$4.21K 0.03% 399
2021
Q3 		$386K Buy
1,595
+56
+4% +$14.1K 0.03% 425
2021
Q2 		$365K Buy
1,539
+206
+15% +$46.9K 0.03% 434
2021
Q1 		$292K Buy
1,333
+161
+14% +$32.3K 0.03% 454
2020
Q4 		$205K Buy
+1,172
New +$202K 0.02% 475

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Corient Capital Partners's LH Position: Q3 2022 in Review

Corient Capital Partners increased its Labcorp (LH) stake by 5.7% in Q3 2022, buying an estimated $19.4K and bringing the position to 1,754 shares worth $353K. The position accounts for 0.03% of the portfolio, ranked #419.

Corient Capital Partners first reported a position in LH in Q4 2020 and has held it in 8 quarters since. The position peaked at $435K in Q4 2021. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

  • Corient Capital Partners held 1,754 shares of Labcorp worth $353K as of Q3 2022.
  • Corient Capital Partners bought 95 Labcorp shares in Q3 2022, an estimated $19.4K.
  • Labcorp made up 0.03% of Corient Capital Partners's portfolio in Q3 2022, its #419 holding.
  • Corient Capital Partners first reported a position in Labcorp in Q4 2020 and has held it in 8 quarters since.
  • Corient Capital Partners's Labcorp position peaked at $435K in Q4 2021.
  • 936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.